Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Don’t expect a Dendreon sale; the troubled biotech will likely end up as a new entity with the current common shares cancelled
Don’t expect a Dendreon sale; the troubled biotech will likely end up as a new entity with the current common shares cancelled
Don’t expect a Dendreon sale; the troubled biotech will likely end up as a new entity with the current common shares cancelled
Submitted by
admin
on November 12, 2014 - 11:02am
Source:
Barron's
News Tags:
Dendreon
bankruptcy
Headline:
Don’t expect a Dendreon sale; the troubled biotech will likely end up as a new entity with the current common shares cancelled
Do Not Allow Advertisers to Use My Personal information